Using transcranial magnetic stimulation, the effect of riluzole (RLZ) on cortical excitability was studied in patients with amyotrophic lateral sclerosis (ALS). Paired-pulse inhibition (PPI) and paired-pulse facilitation (PPF) were reduced. RLZ partially restored deficient PPI in the first of 4 consecutive 3-month periods of testing, but left PPF unchanged. These findings substantiate the view that attenuation of glutamate-related excitotoxicity is an important factor contributing to the beneficial effect of RLZ in ALS.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cortical excitability
8
patients amyotrophic
8
amyotrophic lateral
8
lateral sclerosis
8
effects riluzole
4
riluzole cortical
4
excitability patients
4
sclerosis transcranial
4
transcranial magnetic
4
magnetic stimulation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!